Bionano Genomics Inc (BNGO)
0.2214
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 12:01
Bionano Genomics Enterprise Value: 14.35M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 14.35M |
| November 20, 2024 | 13.36M |
| November 19, 2024 | 14.91M |
| November 18, 2024 | 15.25M |
| November 15, 2024 | 17.10M |
| November 14, 2024 | 18.10M |
| November 13, 2024 | 20.24M |
| November 12, 2024 | 19.02M |
| November 11, 2024 | 20.36M |
| November 08, 2024 | 20.47M |
| November 07, 2024 | 22.05M |
| November 06, 2024 | 22.61M |
| November 05, 2024 | 20.47M |
| November 04, 2024 | 19.11M |
| November 01, 2024 | 19.03M |
| October 31, 2024 | 19.78M |
| October 30, 2024 | 21.98M |
| October 29, 2024 | 19.70M |
| October 28, 2024 | 19.42M |
| October 25, 2024 | 19.05M |
| October 24, 2024 | 18.15M |
| October 23, 2024 | 18.08M |
| October 22, 2024 | 19.22M |
| October 21, 2024 | 20.35M |
| October 18, 2024 | 21.49M |
| Date | Value |
|---|---|
| October 17, 2024 | 20.84M |
| October 16, 2024 | 21.48M |
| October 15, 2024 | 21.18M |
| October 14, 2024 | 22.98M |
| October 11, 2024 | 24.74M |
| October 10, 2024 | 24.74M |
| October 09, 2024 | 29.20M |
| October 08, 2024 | 29.23M |
| October 07, 2024 | 30.33M |
| October 04, 2024 | 32.66M |
| October 03, 2024 | 30.84M |
| October 02, 2024 | 30.19M |
| October 01, 2024 | 29.58M |
| September 30, 2024 | 32.15M |
| September 27, 2024 | 40.25M |
| September 26, 2024 | 38.38M |
| September 25, 2024 | 35.15M |
| September 24, 2024 | 36.54M |
| September 23, 2024 | 34.82M |
| September 20, 2024 | 35.29M |
| September 19, 2024 | 36.54M |
| September 18, 2024 | 34.83M |
| September 17, 2024 | 36.55M |
| September 16, 2024 | 36.07M |
| September 13, 2024 | 37.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-19.04M
Minimum
Oct 27 2023
4.210B
Maximum
Feb 16 2021
432.01M
Average
115.07M
Median
Apr 28 2023
Enterprise Value Benchmarks
| Revvity Inc | 15.48B |
| Bruker Corp | 10.71B |
| Azenta Inc | 1.613B |
| Harvard Bioscience Inc | 127.50M |
| Akoya Biosciences Inc | 145.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -44.25M |
| Revenue (Quarterly) | 6.073M |
| Total Expenses (Quarterly) | 28.70M |
| EPS Diluted (Quarterly) | -0.52 |
| Gross Profit Margin (Quarterly) | -139.1% |
| Profit Margin (Quarterly) | -728.6% |
| Earnings Yield | -2.02K% |
| Normalized Earnings Yield | -1828.67 |